October 5, 2009 - In a bold effort to provide women and their doctors with better information about how and when to take the necessary steps to obtain an early diagnosis for ovarian cancer, the Ovarian Cancer National Alliance has taken the lead in posting guidance for diagnoses on its web site (ovariancancer.org/diary).

The Interim Practice Guidance, endorsed by prominent specialists in the field of gynecologic cancer, marks the first time ovarian cancer diagnostic protocols have been made available to the public. In addition to the guidance, a Symptom Diary that helps women measure the persistency and severity of their symptoms (initially developed in the United Kingdom by Ovarian Cancer Action), has been reproduced in conjunction with the Gynecologic Cancer Foundation, with permission for use in the United States.

Annually, more than 15,000 women die from ovarian cancer, and survival rates have hovered at 40 percent for years, primarily due to the lack of a reliable early detection test, and that many of the symptoms often mimic other, less life-threatening problems.

Karen Orloff Kaplan, CEO of the Ovarian Cancer National Alliance believes this important information should be shared publicly to help women with ovarian cancer get diagnosed sooner. “Giving women the information they need to more effectively listen to their bodies and recognize the symptoms of ovarian cancer can help reduce the number of deaths from this hideous disease. By using the Symptom Diary and the Interim Practice Guidance, we believe that more lives can be saved.”
Barbara Goff, M.D. of the Seattle Cancer Care Alliance also endorsed the preparation and release of the guidance. “I think this guidance is important because the symptoms of ovarian cancer are very common and we all have them from time to time. This guidance summary provides information to practitioners and women about when symptoms may be concerning for ovarian cancer and what are the possible diagnostic tests that can be done if ovarian cancer is of concern.”
For more information: www.ovariancancer.org/diary

Related Content

News | Mammography

October 19, 2021 — If Black women begin mammography screening every other year starting at age 40, breast cancer deaths ...

Time October 19, 2021
arrow
News | Ultrasound Imaging

October 15, 2021 — NeuroLogica Corp., the U.S. healthcare subsidiary of Samsung, introduces the V8; a high-end ...

Time October 15, 2021
arrow
News | Ultrasound Women's Health

October 14, 2021 — In a first-in-world clinical trial, researchers at Sunnybrook Health Sciences Centre in Toronto ...

Time October 14, 2021
arrow
News | Breast Imaging

October 14, 2021 — Delphinus Medical Technologies, Inc. announced that the U.S. Food and Drug Administration (FDA) has ...

Time October 14, 2021
arrow
News | Women's Health

October 11, 2021 — Electrical engineering professor Magda El-Shenawee’s effort to develop a more accurate and less ...

Time October 11, 2021
arrow
News | Women's Health

October 8, 2021 — An analysis of nearly 200,000 patients who received mammograms between 2006 and 2015 across three U.S ...

Time October 08, 2021
arrow
News | MRI Breast

October 7, 2021 — An automated system that uses artificial intelligence (AI) can quickly and accurately sift through ...

Time October 07, 2021
arrow
News | Women's Health

October 6, 2021 — A commentary by Mayo Clinic Cancer Center researchers published in the Journal of Clinical Oncology ...

Time October 06, 2021
arrow
News | Women's Health

October 5, 2021 — A promising radionuclide treatment may offer new therapeutic options for breast cancer patients ...

Time October 05, 2021
arrow
News | Women's Health
October 4, 2021 — Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health ...
Time October 04, 2021
arrow
Subscribe Now